Skip to main content
. 2013 Feb 1;14(2):95–99. doi: 10.4161/cbt.22960

graphic file with name cbt-14-95-g3.jpg

Figure 3. Primary Ki-CA patient tumor immunohistochemistry. Tumor exhibited both Src positivity (A) and VHL positivity (B). Power: 20 × ; Scale bar: 20 μM

HHS Vulnerability Disclosure